Both Drs

Both Drs. are associated with prescription adaptations and renewals. Discussion In a recent survey of Canadian policymakers, many respondents ranked the issue of prescribing privileges as one of their most pressing policy questions. No matter the results of our study, they will be important for policymakers, as our data will make policy decisions surrounding pharmacist prescribing more evidence-based. Background Context Access to primary care is an important concern ACA for patients in almost every jurisdiction examined. In Canada, nearly 4 million individuals report not having a regular physician and over 2 million report difficulties in accessing routine or ongoing care [1]. For at least some of these individuals, and for certain components of primary health care, non-physician health professionals may represent high-quality alternatives. There is some research evidence on the potential of deploying pharmacists in primary care [2]; that literature, and practical experience in other jurisdictions points to a considerable amount of untapped pharmacist human resources [3-7]. Expanding the scope of pharmacy practice may be a cost-effective way to enhance patient access and adherence to medicines, and to reduce the clinical burden on primary care physicians. Around 53% of Canadians fill one or more prescriptions each year, and at least half of these represent chronic medications used to manage cardiovascular risk factors [8,9]. However, rates of continuous use of medicines for chronic conditions are often sub-optimal [10]. But with prescription lengths limited to approximately 3 months in most provinces (with up to 4 refills if they are provided), access to primary care doctors for the purpose of prescription renewal may be a barrier to continuous adherence to long-term drug therapies. Thus, granting pharmacists prescribing authority may increase Canadians’ access to medications. Though pharmacists are highly trained in matters related to the effects, interactions, and appropriate use of medicines, their expertise is seldom called upon as a first-line primary health care provider in community settings. Recently, numerous Canadian provinces have implemented programs designed to expand the scope of pharmacy practice. The first province to move in this direction was Alberta, which implemented a program in 2007 that allows pharmacists to prescribe medications and adapt existing prescriptions [3]. One year later, three-quarters of pharmacists in the province reported that they regularly renewed or adapted prescriptions [11]. Several other provinces allow pharmacists similar prescribing privileges, and the remaining provinces have passed the enabling legislation to allow ACA pharmacist prescribing in the future. The trend towards pharmacist prescribing is present internationally as well. The United Kingdom has introduced “independent prescribing”, which gives pharmacists the ability to prescribe all medications after completing a training program. Likewise, in the United States, collaborative drug therapy management by pharmacists is permitted ACA by the federal government and by at least 40 individual states [3]. All of these changes granting pharmacists prescribing authority may have significant implications for quality of care. Policy Change: A Natural Experiment A January 2009 policy change in the Canadian province of United kingdom Columbia (BC) has an possibility to generate precious information regarding the influences of adjustments in pharmacists’ prescribing power. This plan allowed pharmacists to adjust existing prescriptions with no consent of the initial prescriber [12]. The plan was adopted predicated on the potential FLT3 advantage of increased affected individual adherence to.